Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1969 Jul;36(3):611–622. doi: 10.1111/j.1476-5381.1969.tb08016.x

Liberation of a bradykinin-like substance in the circulating blood of dogs by trypsin, chymotrypsin and nagarse

S H Ferreira, M Rocha E Silva
PMCID: PMC1703611  PMID: 5789813

Abstract

1. Using the blood-bathed organ technique with cat jejunum as the test organ, it was shown that kinin was regularly released by infusions of trypsin, chymotrypsin and nagarse into the blood superfusing the tissue or into the jugular vein of dogs.

2. Intravenous injections of the three enzymes, in doses which did not change plasma bradykininogen (BKG) level, induced generation of kinin in the circulating blood.

3. Nagarse in kinin-liberating concentrations did not liberate angiotensin in the circulating blood.

4. The responses of the cat jejunum strip, and the systemic hypotension induced by the three enzymes, were enhanced by treatment of the dog with a bradykinin potentiator.

5. Injection of the enzymes in the blood perfused hind leg of the dog caused a fall in the vascular resistance. In this preparation, bradykinin potentiating factor (BPF) potentiated trypsin, but not the effects of chymotrypsin and nagarse injections.

6. It is suggested that the blood pressure lowering effect of low doses of trypsin is due mainly to kinin release. Chymotrypsin and nagarse, in addition to having a direct action on the vascular smooth muscles, also have indirect hypotensive effects due to the liberation of kinin.

Full text

PDF
611

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Corrado A. P., Reis M. L., Carvalho I. F., Diniz C. R. Bradykininogen and bradykinin in the cardiovascular shock produced by proteolytic enzymes. Biochem Pharmacol. 1966 Jul;15(7):959–970. doi: 10.1016/0006-2952(66)90173-0. [DOI] [PubMed] [Google Scholar]
  2. DINIZ C. R., CARVALHO I. F. A micromethod for determination of bradykininogen under several conditions. Ann N Y Acad Sci. 1963 Feb 4;104:77–89. doi: 10.1111/j.1749-6632.1963.tb17654.x. [DOI] [PubMed] [Google Scholar]
  3. DINIZ C. R., CARVALHO I. F., RYAN J., ROCHA E SILVA M. A micromethod for the determination of bradykininogen in blood plasma. Nature. 1961 Dec 23;192:1194–1195. doi: 10.1038/1921194a0. [DOI] [PubMed] [Google Scholar]
  4. EDERY H. POTENTIATION OF THE ACTION OF BRADYKININ ON SMOOTH MUSCLE BY CHYMOTRYPSIN, CHYMOTRYPSINOGEN AND TRYPSIN. Br J Pharmacol Chemother. 1964 Apr;22:371–379. doi: 10.1111/j.1476-5381.1964.tb02042.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. ERDÖS E. G., WOHLER J. R. INHIBITION IN VIVO OF THE ENZYMATIC INACTIVATION OF BRADYKININ AND KALLIDIN. Biochem Pharmacol. 1963 Oct;12:1193–1199. doi: 10.1016/0006-2952(63)90094-7. [DOI] [PubMed] [Google Scholar]
  6. FERREIRA S. H. A BRADYKININ-POTENTIATING FACTOR (BPF) PRESENT IN THE VENOM OF BOTHROPS JARARCA. Br J Pharmacol Chemother. 1965 Feb;24:163–169. doi: 10.1111/j.1476-5381.1965.tb02091.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. FERREIRA S. H., ROCHA E SILVA M. Potentiation of bradykinin by dimercaptopropanol (bal) and other inhibitors of its destroying enzyme in plasma. Biochem Pharmacol. 1962 Dec;11:1123–1128. doi: 10.1016/0006-2952(62)90190-9. [DOI] [PubMed] [Google Scholar]
  8. Ferreira S. H., Rocha e Silva M. Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) from Bothrops jararaca venom. Experientia. 1965 Jun 15;21(6):347–349. doi: 10.1007/BF02144709. [DOI] [PubMed] [Google Scholar]
  9. Ferreira S. H., Vane J. R. The detection and estimation of bradykinin in the circulating blood. Br J Pharmacol Chemother. 1967 Mar;29(3):367–377. doi: 10.1111/j.1476-5381.1967.tb01968.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. PRADO J. L., PRADO E. S., JURKIEWICZ A. CRYSTALLINE BACTERIAL PROTEINASE FROM B. SUBTILIS (NAGARSE) AS A NEW KININOGENASE. Arch Int Pharmacodyn Ther. 1964 Jan 1;147:53–68. [PubMed] [Google Scholar]
  11. REGOLI D., VANE J. R. A SENSITIVE METHOD FOR THE ASSAY OF ANGIOTENSIN. Br J Pharmacol Chemother. 1964 Oct;23:351–359. doi: 10.1111/j.1476-5381.1964.tb01591.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rocha e Silva M., Reis M. L., Ferreira S. H. Release of kinins from fresh plasma under varying experimental conditions. Biochem Pharmacol. 1967 Sep 9;16(9):1665–1676. doi: 10.1016/0006-2952(67)90241-9. [DOI] [PubMed] [Google Scholar]
  13. VANE J. R. THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD. Br J Pharmacol Chemother. 1964 Oct;23:360–373. doi: 10.1111/j.1476-5381.1964.tb01592.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES